The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Everolimus in patients with advanced, progressive pancreatic neuroendocrine tumors: Overall survival results from the phase III RADIANT-3 study after adjusting for crossover bias.
 
Marianne E. Pavel
Honoraria - Ipsen; Lexicon; Novartis; Pfizer
Consulting or Advisory Role - Ipsen; Lexicon; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Catherine Lombard-Bohas
Consulting or Advisory Role - Ipsen; Novartis
 
Eric Van Cutsem
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Du Hung Lam
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Tiffany Kunz
Leadership - Novartis
Stock and Other Ownership Interests - Novartis
 
Ulrike Brandt
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jaume Capdevila
No Relationships to Disclose
 
Elisabeth De Vries
Research Funding - Amgen (Inst); Novartis (Inst); Pieris Pharmaceuticals (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Amgen; roche
 
Paola Tomassetti
No Relationships to Disclose
 
Timothy J. Hobday
Research Funding - Novartis (Inst)
 
Rodney F. Pommier
Honoraria - Novartis
Consulting or Advisory Role - Novartis; Pfizer
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Novartis; Pfizer
 
James C. Yao
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Research Funding - Novartis (Inst)